Charles V. Clevenger

6.4k total citations
102 papers, 5.2k citations indexed

About

Charles V. Clevenger is a scholar working on Molecular Biology, Oncology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Charles V. Clevenger has authored 102 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Molecular Biology, 54 papers in Oncology and 30 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Charles V. Clevenger's work include Cytokine Signaling Pathways and Interactions (28 papers), Growth Hormone and Insulin-like Growth Factors (26 papers) and Estrogen and related hormone effects (14 papers). Charles V. Clevenger is often cited by papers focused on Cytokine Signaling Pathways and Interactions (28 papers), Growth Hormone and Insulin-like Growth Factors (26 papers) and Estrogen and related hormone effects (14 papers). Charles V. Clevenger collaborates with scholars based in United States, Philippines and Canada. Charles V. Clevenger's co-authors include J. Bradford Kline, Alan L. Epstein, Michael B. Prystowsky, Susan E. Hankinson, Michael A. Rycyzyn, Priscilla A. Furth, Linda A. Schuler, Kenneth D. Bauer, Samantha Gadd and Winnie Ngo and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Charles V. Clevenger

99 papers receiving 5.1k citations

Peers

Countries citing papers authored by Charles V. Clevenger

Since Specialization

Citations

This map shows the geographic impact of Charles V. Clevenger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles V. Clevenger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles V. Clevenger more than expected).

Fields of papers citing papers by Charles V. Clevenger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles V. Clevenger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles V. Clevenger. The network helps show where Charles V. Clevenger may publish in the future.

Co-authorship network of co-authors of Charles V. Clevenger

This figure shows the co-authorship network connecting the top 25 collaborators of Charles V. Clevenger. A scholar is included among the top collaborators of Charles V. Clevenger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles V. Clevenger. Charles V. Clevenger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Evaluation of the NRF1-proteasome axis as a therapeutic target in breast cancer 2023 ·Scientific Reports ·(unknown), (unknown), Janakiram R. Vangala, (unknown), (unknown), Charles V. Clevenger, J. Chuck Harrell, Senthil K. Radhakrishnan	4
2	Breast Cancer and Prolactin – New Mechanisms and Models 2022 ·Endocrinology ·Charles V. Clevenger, Hallgeir Rui	16
3	Inhibition of the Activity of Cyclophilin A Impedes Prolactin Receptor-Mediated Signaling, Mammary Tumorigenesis, and Metastases 2020 ·iScience ·(unknown), Justin M. Craig, Jennifer E. Koblinski, Charles V. Clevenger	7
4	Cyclophilin A Function in Mammary Epithelium Impacts Jak2/Stat5 Signaling, Morphogenesis, Differentiation, and Tumorigenesis in the Mammary Gland 2018 ·Cancer Research ·Sonja E. Volker, (unknown), (unknown), Charles V. Clevenger	18
5	A pilot study of cabergoline for the treatment of metastatic breast cancer 2017 ·Breast Cancer Research and Treatment ·Ricardo Costa, Cesar A. Santa‐Maria, Denise Scholtens, Suneil Jain, Lisa Flaum, William J. Gradishar, Charles V. Clevenger, Virginia Kaklamani	16
6	HDAC6 Deacetylates HMGN2 to Regulate Stat5a Activity and Breast Cancer Growth 2016 ·Molecular Cancer Research ·Terry R. Medler, Justin M. Craig, Alyson A. Fiorillo, (unknown), J. Chuck Harrell, Charles V. Clevenger	36
7	Identification of NEK3 Kinase Threonine 165 as a Novel Regulatory Phosphorylation Site That Modulates Focal Adhesion Remodeling Necessary for Breast Cancer Cell Migration 2016 ·Journal of Biological Chemistry ·(unknown), Charles V. Clevenger	19
8	Immunoassay and Nb2 lymphoma bioassay prolactin levels and mammographic density in premenopausal and postmenopausal women the Nurses’ Health Studies 2014 ·Breast Cancer Research and Treatment ·Megan S. Rice, Shelley S. Tworoger, Kimberly A. Bertrand, Susan E. Hankinson, Bernard Rosner, (unknown), Charles V. Clevenger, Rulla M. Tamimi	7
9	Prolyl Isomerase Cyclophilin A Regulation of Janus-Activated Kinase 2 and the Progression of Human Breast Cancer 2008 ·Cancer Research ·Jiamao Zheng, Jennifer E. Koblinski, (unknown), (unknown), Charles V. Clevenger	61
10	From Bench to Bedside: Future Potential for the Translation of Prolactin Inhibitors as Breast Cancer Therapeutics 2008 ·Journal of Mammary Gland Biology and Neoplasia ·Charles V. Clevenger, Jiamao Zheng, Elizabeth M. Jablonski, (unknown), Feng Fang	28
11	Quantification of PRL/Stat5 signaling with a novel pGL4-CISH reporter 2008 ·BMC Biotechnology ·Feng Fang, Giovanni Antico, Jiamao Zheng, Charles V. Clevenger	34
12	Roles and Regulation of Stat Family Transcription Factors in Human Breast Cancer 2004 ·American Journal Of Pathology ·Charles V. Clevenger	164
13	Identification and Characterization of the Prolactin-binding Protein in Human Serum and Milk 2001 ·Journal of Biological Chemistry ·J. Bradford Kline, Charles V. Clevenger	62
14	Prolactin as a Chemoattractant for Human Breast Carcinoma 1999 ·Endocrinology ·Marcela V. Maus, (unknown), Charles V. Clevenger	92
15	Role of Bag-1 in the Survival and Proliferation of the Cytokine-Dependent Lymphocyte Lines, Ba/F3 and Nb2 1997 ·Molecular Endocrinology ·Charles V. Clevenger	18
16	Expression of Prolactin and Its Receptor in Human Breast Carcinoma¹ 1997 ·Endocrinology ·Carol Reynolds, Kathleen T. Montone, (unknown), John E. Tomaszewski, Charles V. Clevenger	165
17	Role of Bag-1 in the Survival and Proliferation of the Cytokine-Dependent Lymphocyte Lines, Ba/F3 and Nb2 1997 ·Molecular Endocrinology ·Charles V. Clevenger, (unknown), Winnie Ngo, Wan‐Pin Chang, Shinichi Takayama, John C. Reed	86
18	Vav Is Necessary for Prolactin-stimulated Proliferation and Is Translocated into the Nucleus of a T-cell Line 1995 ·Journal of Biological Chemistry ·Charles V. Clevenger, Winnie Ngo, Deborah L. Sokol, Selina M. Luger, Alan M. Gewirtz	97
19	Detection of Bone Marrow Breast Carcinoma Metastasis Using Multiparameter Flow Cytometry 1993 ·Annals of the New York Academy of Sciences ·Charles V. Clevenger, (unknown), E. Stadtmauer, Lori Jardines	7
20	Colchicine Poisoning: Report of a Fatal Case with Body Fluid Analysis by GC/MS and Histopathologic Examination of Postmortem Tissues 1991 ·Journal of Analytical Toxicology ·Charles V. Clevenger, (unknown), Yi‐Ju Li	47

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact